Delivery Order SPE2DB25D2204-SPE2DB25FTGWJ
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a competitive delivery order on August 5, 2025, by the Defense Logistics Agency to supply 100 tablets of Adderall 20 mg. The contract is a firm fixed-price delivery order with a ceiling value of $10,740.13 and an ultimate completion date of August 6, 2025. This award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 25, 2025, for the supply of Adderall 20 mg tablets (100-count). This competitive award, with a ceiling value of $4,056.85 and a firm fixed price structure, is scheduled for ultimate completion by July 28, 2025. The delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 12, 2025, for the supply of Adderall 20 mg tablets in quantities of 100 units. This firm fixed price contract, valued at $2,099.42, represents a non-competitive set-aside delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor agreement running...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 12, 2025, with a ceiling value of $10,926.83 for the supply of Adderall 5 mg tablets in quantities of 100. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 13, 2025, and represents a non-set-aside competitive award. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical with a potential value of $1,533.75. The contract is for the delivery of 100 units of Adderall 30 mg tablets to a location in Conshohocken, Pennsylvania. This delivery order is placed under an existing indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,325.97 for 100 tablets of Adderall 30mg on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $3,727.50 to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of Adderall 5 mg tablets in 100-count bottles. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00, which AmerisourceBergen holds with DLA Troop Support Medical. The IDC allows DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies to...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $9,835.93 firm fixed price delivery order contract from the Defense Logistics Agency (DLA) to provide Adderall 15 mg tablets. The contract has a completion date of February 20, 2024. This delivery order is issued under an existing indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver pharmaceuticals and medical...
- This $1,815.48 firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4,565,764 units of 5 mg Adderall tablets. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which provides a comprehensive range of...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for 100 tablets of Adderall 5 mg, valued at $3,798.06. The contract was awarded on July 25, 2025, on a firm fixed-price basis with an ultimate completion date of July 28, 2025. The award was not designated as a set-aside and represents a competitively awarded delivery order to be fulfilled at the vendor's Conshohocken, Pennsylvania location. This delivery order is a child contract executed under...
- SPE2DB25D2204Indefinite Delivery Contract
- SPE2DB25D2204-SPE2DB25FTGWJDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency valued at $3,165.05 for 100 tablets of Adderall 20 mg. The contract, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a firm fixed price delivery order with no set-aside designation. This award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The delivery order supports the Defense Logistics Agency's Medical Supply Chain operations and contributes to federal pharmaceutical procurement requirements for military and veteran healthcare systems. AmerisourceBergen's extensive federal contract portfolio demonstrates its capability to supply a comprehensive range of pharmaceutical products, from brand-name and generic medications to specialized medical supplies across multiple therapeutic domains. The company's continued awards under the Pharmaceutical Prime Vendor Global Program reflect its critical role in supporting Defense Health Agency and other government healthcare systems through flexible and comprehensive contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 8/13/25 |